Pain Evaluation Across Robotic and Laparoscopic Surgery for Colorectal Procedures
PEARL
1 other identifier
observational
80
1 country
1
Brief Summary
Minimally invasive surgery for colorectal conditions, such as laparoscopic or robotic surgery, has been shown to offer benefits over traditional open surgery. These benefits include less pain after surgery, shorter hospital stays, and fewer complications. This study aims to compare two types of minimally invasive surgery-laparoscopic and robotic surgery-to determine which approach results in less postoperative pain for patients undergoing colon or rectal surgery. The central hypothesis is that robotic surgery, due to its higher precision and reduced tissue trauma, will lead to lower pain levels after surgery. The study will enroll adult patients scheduled for elective colorectal surgery at the Hospital General Universitario Gregorio Marañón in Madrid. Participants will undergo either laparoscopic or robotic surgery based on clinical availability and surgical planning, as long as they meet all inclusion criteria under the hospital's enhanced recovery protocol (RICA program). Researchers will assess patients' pain levels at different time points after surgery (immediately after recovery, at 24, 48, and 72 hours, and at discharge) using validated pain scales. The use of pain medications, hospital stay duration, complication rates, and quality of life up to 12 months after surgery will also be measured. All patient data will be collected anonymously using a secure electronic system (REDCap). The study will last approximately 2 years and include about 80 patients (40 in each group). The results could help surgeons and hospitals choose the most effective surgical approach to reduce postoperative pain and improve patient recovery in colorectal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
ExpectedFebruary 25, 2026
February 1, 2026
6 months
July 1, 2025
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain
Assessment of patient-reported postoperative pain at 24 hours after surgery, using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain).
24 hours
Secondary Outcomes (17)
Postoperative Pain at 48 Hours Measured by Visual Analog Scale (VAS)
48 hours post-surgery
Postoperative Pain at 72 Hours Measured by Visual Analog Scale (VAS)
72 hours post-surgery
Intraoperative Analgesic Consumption
Intraoperative period
Postoperative Analgesic Consumption
From recovery room admission up to 72 hours after surgery.
Postoperative Morbidity (Clavien-Dindo Classification)
Within 30 days after surgery
- +12 more secondary outcomes
Study Arms (2)
Laparoscopic Surgery
Laparoscopic procedure
Robotic Surgery
Robotic Procedure
Eligibility Criteria
Adult patients (≥18 years) undergoing elective colorectal surgery (right or left colon resection) for malignant disease at the Hospital General Universitario Gregorio Marañón (Madrid, Spain), following the hospital's Enhanced Recovery After Surgery (ERAS) protocol (RICA program). All participants must meet strict inclusion criteria, including cognitive capacity and ASA I-III classification, and must consent to participate. Patients will receive either laparoscopic or robotic surgical approach based on surgical planning and equipment availability. The study will exclude individuals with prior chronic opioid use, certain comorbidities, or those requiring open surgery or multivisceral resection.
You may qualify if:
- Adults aged 18 years or older
- Signed informed consent
- Adequate cognitive status
- ASA (American Society of Anesthesiologists) classification I, II, or III
- Elective colon surgery (right or left hemicolectomy) for malignant disease
- Planned laparoscopic or robotic surgical approach
- Preoperative evaluation completed as per RICA protocol (nutritional, nursing, anesthetic, and pharmacy assessments)
You may not qualify if:
- Patients with a preoperative decision for open surgery
- Patients undergoing rectal surgery (partial or total mesorectal excision without protective stoma)
- Patients with inflammatory bowel disease requiring colorectal resection
- Patients requiring multivisceral resection due to oncologic indications identified intraoperatively
- Extraction incision different from Pfannenstiel approach
- Current or past history of chronic opioid use or opioid abuse
- Current or past history of benzodiazepine use or abuse
- Chronic use of analgesics for other comorbid medical conditions
- Current or past history of recreational drug use or abuse
- Non-compliance with the RICA protocol, including:
- Lack of preoperative nutritional, nursing, anesthetic, or pharmacy evaluation
- Non-adherence to preoperative care protocols (e.g., premedication, fasting, carbohydrate loading, thromboembolism prophylaxis, antibiotic prophylaxis, anesthetic care guidelines)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Gregorio Marañon
Madrid, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patricia Tejedor Patricia Tejedor, M.D.,Ph.D.
University Hospital Gregorio Marañón
Central Study Contacts
Joaquín Mascaró Joaquín Mascaró, M.D.
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Ph.D.
Study Record Dates
First Submitted
July 1, 2025
First Posted
February 25, 2026
Study Start
September 1, 2025
Primary Completion
February 28, 2026
Study Completion (Estimated)
September 1, 2028
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to patient confidentiality concerns and institutional data protection policies. Additionally, the study is single-center with a limited sample size, and there is no formal data-sharing infrastructure or repository in place for this project.